German biopharma ARTES follows GSK’s malaria vaccine announcement
The German biopharmaceutical company ARTES has announced it is developing a malaria vaccine with Australian non-profit the Burnet Institute.
Archives for July 28, 2014
Boehringer Ingelheim forges $395m peptide deal with Zealand
Boehringer Ingelheim has entered a collaboration to develop a peptide candidate for cardio-metabolic diseases in a deal that could net partner Zealand Pharma up to €295m ($395m).
PaxVax acquires typhoid vaccine, Swiss manufacturing facility
Specialty vaccine company PaxVax has acquired the oral typhoid vaccine Vivotif from Crucell, as well as its manufacturing facility in Thörishaus, Switzerland. Financial terms of the transaction were not disclosed.